Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company operates as a pharmaceutical company. It offers active pharmaceutical ingredients and finished dosages.
Msn Laboratories Private Limited, is an unlisted private company incorporated on 27 August, 2003. It is classified as a private limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 10.00 cr and the total paid-up capital is INR 5.20 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Manne Laxmi Prasuna
Shareholder
|
00954334 | 23 years |
| Director | Bharat Reddy Chintapally
Shareholder
|
01591473 | 20 years |
| Managing Director | Satyanarayana Reddy Manne
Shareholder
|
01657567 | 23 years |
| Company Secretary | Vinod Kumar Chawla | 07951407 | 14 years |
| Director | Achyuth Reddy Manne | 08170401 | 1 years |
| Director | Sindhuja Reddy Manne | 02977495 | 1 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 5
Total Amount : 1,300.0 cr
The Federal Bank Limited
No. of Loans: 4
Total Amount : 675.0 cr
Axis Bank Limited
No. of Loans: 38
Total Amount : 647.9 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 635.0 cr
Canara Bank
No. of Loans: 1
Total Amount : 600.0 cr
ICICI Bank Limited
No. of Loans: 2
Total Amount : 515.0 cr
Bajaj Finance Limited
No. of Loans: 4
Total Amount : 375.0 cr
Bank of India
No. of Loans: 1
Total Amount : 373.3 cr
BANDHAN BANK LIMITED
No. of Loans: 2
Total Amount : 325.0 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 300.0 cr
Yes Bank Limited
No. of Loans: 1
Total Amount : 250.0 cr
CSB BANK LIMITED
No. of Loans: 2
Total Amount : 210.0 cr
Indian Bank
No. of Loans: 1
Total Amount : 200.0 cr
CitiBank N.A.
No. of Loans: 2
Total Amount : 185.0 cr
IndusInd Bank Limited
No. of Loans: 1
Total Amount : 155.0 cr
Punjab National Bank
No. of Loans: 1
Total Amount : 100.0 cr
Aditya Birla Finance Limited
No. of Loans: 1
Total Amount : 100.0 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| MSN Pharmaceuticals Inc | United States | - | - |
| MSNLabs Americas S.A.S | Colombia | - | - |
| MSN Laboratories Europe Limited | United Kingdom | - | - |
| MSN Life Care SA DE CV | Mexico | - | - |
| MSN Labs Peru S A C | Peru | - | - |
| MSN Labs Chile SPA | Chile | - | - |
| MSN Labs Europe Limited | Malta | - | - |
| Vivanta Generics SRO | Czech Republic | - | - |
| MSN Labs Malaysia SDN BHD | Malaysia | - | - |
Read more
The incorporation date of MSN LABORATORIES PRIVATE LIMITED is 27 August, 2003
The authorized share capital of MSN LABORATORIES PRIVATE LIMITED is INR ₹ 10.0 Cr.
The paid-up capital of MSN LABORATORIES PRIVATE LIMITED is INR ₹ 5.2 Cr.
The registered address of MSN LABORATORIES PRIVATE LIMITED is MSN HOUSE, PLOT NO. C 24, SANATH NAGAR INDUSTRIAL ESTATE, SANATH N AGAR HYDERABAD Telangana - 500018
The CIN number of MSN LABORATORIES PRIVATE LIMITED is U24239TG2003PTC041583.